Abstract
Thymosin fraction V, one of the most important hormonal-like peptides produced by the thymus, has been shown to be a useful agent in treating patients with primary and secondary immunodeficiency diseases (4). Thymus Factor X (TFX), an extract corresponding to thymosin fraction V prepared from calf thymus by Polfa Pharmaceuticals (Jelenia Góra, Poland) has been found to have similar immunomodulating properties (3). Thymic factors participate in the process of immune regulation by affecting the functions of various T lymphocyte subsets. Therefore, it may be anticipated that the final effect of their action depends on a number of factors including the immune status of a patient and the conditions of administration. This may explain why a thymic factor can cause opposing effects in vitro, and when administered in vivo, may lead to both amelioration and aggravation in the same clinical situation (15). We have recently shown that TFX is a potent inducer of helper T cells for antibody production in man. However, when TFX is added to lymphocytes generating high numbers of plasma cells in culture the resulting immunoglobulin synthesis is markedly reduced (7, 8). This data indicates that in some situations thymosin could have immunosuppressive properties. This further suggests the feasibility of combining TFX with immunosuppressive drugs which might be a more efficient immunosuppressive protocol to inhibit humoral responses.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bach, J. F., M. Dardanne, and A. J. S. Davies. 1971. Early effect of adult thymectomy. Nature 231: 110.
Dabrowski, M. P., and A. L. Goldstein. 1976. Thymosin induced changes in the cell cycle of lymphocytes from aging neonatally thymectomized rats. Tmmunol. Commun. 5: 695.
Dabrowski, M. P., B. K. Dabrowska-Bernstein, W. J. Brzosko, L. Babiuch, and B. Kassur. 1980. Maturation of human T lymphocytes under the influence of calf thymus hormone. Clin. Immun. Immunopath. 16: 297.
Goldstein, A. L., T. L. K. Low, G. B. Thurman, M. M. Zatz, N. Hall, J. Chen, S. K. Hu, P. B. Naylor, and J. E. McClure. 1981. Current status of thymosin and other hormones of the thymus gland. Recent Prog. Horm. Res. 37: 369.
Golightly, M. G., and S. H. Golub. 1980. The in vitro culture characteristic and requirements for expression of receptors for IgM on human peripheral blood lymphocytes. Clin. Exp. Immunol. 39: 227.
Gorski, A., A. B. Skotnicki, Z. Gaciong, and G. Korczak. 1981. The effect of calf thymus extract ( TFX) on human and mouse hematopoiesis. Thymus 3: 129.
Górski, A., G. Korczak-Kowalska, Z. Gaciong and L. Paczek. 1982. Transient hypogammaglobulinemia of infancy. New Engl. J. Med. 306: 939.
Górski, A., G. Korczak-Kowalska, M. Nowaczyk, Z. Gaciong, and E. Skopinska-Rozewska. 1982. Thymosin (TFX): an immunomodulator of antibody production in man. Immunology 47: (in press).
Górski, A., M. Nowaczyk, G. Korczak-Kowalska, M. Wasik, I. Podobinska, M. Malejczyk, Z. Gaciong and L. Paczek. 1983. Mode of action of cyclophosphamide as assessed by in vitro activity of its active metabolite. Transplant. Proc. (in press).
Jaffers, G., R. B. Colvin, A. B. Cosimi, J. V. Giorgi, T. C. Fuller, C. Lillehei, and P. S. Russell. 1983. The human immune response to murine OKT3 monoclonal antibody. Transplant. Proc. (in press).
Lipson, S. D., P. B. Chretien, R. Maluch, D. E. Kenady, and M. K. Cohen. 1979. Thymosin immunotherapy in patients with small cell carcinoma of the lung. Cancer 43: 863.
Otterness, I. G., and Y. H. Chang. 1976. Comparative study of cyclophosphamide, 6-mercaptopurine, azathioprine and methotrexate. Clin. Exp. Immunol. 26: 346.
Spiegelberg, H. L., and P. M. Dainer. 1979. Fc receptors for IgG, IgM and IgE on human leukaemic lymphocytes. Clin. Exp. Immunol. 35: 286.
Squifflet, J. P., D. E. R. Sutherland, J. Field, J. Rynasiewicz, and J. Keil. 1982. Synergistic immunosuppressive effect of cyclosporin A and azathioprine. IX International Congress of the Transplantation Society, Brighton. (abstract).
Touraine, J. L., and R. A. Good. 1982. Therapy communication session on thymic hormones. Thymus 4: 57.
Wasik, M., L. Gradowska, D. Rowinska, M. Lao, and T. Orlowski. 1981. Diagnostic and prognostic value of ADCC and lectininduced cellular cytotoxicity tests for renal allograft rejection. Transplantation 32: 217.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gorski, A., Rancewicz, Z., Nowaczyk, M., Malejczyk, M., Waski, M. (1983). Diminished Synthesis of Immunoglobulins by Lymphocytes of Patients Treated with Thymosin (TFX) and Cyclophosphamide. In: Klein, T., Specter, S., Friedman, H., Szentivanyi, A. (eds) Biological Response Modifiers in Human Oncology and Immunology. Advances in Experimental Medicine and Biology, vol 166. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1410-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1410-4_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1412-8
Online ISBN: 978-1-4757-1410-4
eBook Packages: Springer Book Archive